SF Healthcare Week: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year
BiotechTV - News
00:00
Marc reflects on Abivax's breakout year
Marc de Garidel recounts the 2025 data, fundraising, stock surge, and focus on bringing obefazimod to patients.
Play episode from 00:30
Transcript
